⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 6, 2024Open Access

Supplementary Figure S5 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency

Aditya Kulkarni Jianli Zhou Neha Biyani Umesh Kathad Partha P. Banerjee Shiv Srivastava Zsombor Prucsi Kamil Solarczyk Kishor Bhatia Reginald B. Ewesuedo Panna Sharma

View Full Paper

Ask AI

Bookmark

Share

Abstract

Figure S5 shows the in vivo tumor response in a TNBC PDX model to LP-184 in combination with Olaparib

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kulkarni et al. (2024) studied this question.

synapsesocial.com/papers/68e6b6d8b6db64358763787d https://doi.org/10.1158/2767-9764.25757522

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S5 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024
2Supplementary Figure S4 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024
3Supplementary Figure S4 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024
4Supplementary Figure S9 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024
5Supplementary Figure S9 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024

Supplementary Figure S10 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024
Supplementary Figure S10 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024
Supplementary Figure S3 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024